A groundbreaking Nature study reports researchers have used CRISPR gene editing technology to correct a mutation that causes hypertrophic cardiomyopathy in embryos. The technique also prevents the mutation from passing to future generations.
CRISPR gene editing has allowed researchers to prevent angiogenesis of the retina occurring in mice. Researchers say the new technology could help prevent vision loss in those with retinal diseases.
CRISPR technology allows researchers to illuminate and monitor alpha synuclein in the brain.
Stimulating microglial cells could delay the onset of some neurodegenerative diseases, researchers report.
Researchers report they have successfully been able to shut down and eliminate the HIV-a virus from infected cells in mice, thanks to the help of CRISPR/Cas9 gene editing technology.
Researchers show CRISPR/Cas9 gene editing technology can be effectively used in rhesus monkey embryos.
Researchers use gene editing to reverse cell degeneration and restore vision in mouse models of retinitis pigmentosa.
Researchers successfully use CRISPR-Cpf1 to correct Duchenne muscular dystrophy in both animal and human cells.
Researchers use CRISPR to modulate genes in order to reduce tissue damage and inflammation for people with neck and back pain.
Researchers use gene editing technology to help partially restore vision to blind rodents.
A new study has identified a biological pathway associated with the risk for developing an eating disorder.
Researchers have developed a new protein that can alter DNA in living cells with much higher precision than current methods.
